Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Syridex Bio, based in Princeton, NJ, focuses on creating companies that address health inequities. They invest in seed and Series A stages, primarily in biotech and healthcare sectors. The firm is dedicated to translating scientific innovations into sustainable ventures aimed at improving health outcomes.
Syridex Bio invests in life sciences companies that develop solutions for diseases affecting underserved populations. Their check sizes and specific investment amounts are not disclosed, but they emphasize rigorous diligence and building well-capitalized companies in emerging fields of science and medicine.
Notable companies in Syridex Bio's portfolio include Antigenix Therapeutics, a preclinical oncology firm developing next-generation antibody-drug conjugates for aggressive cancers, and Qunova, a digital health company focused on an AI-driven platform for optimizing population health strategies.
Email info@syridexbio.com with your deck to pitch Syridex Bio.
Syridex Bio often leads investment rounds, particularly in seed and Series A stages, to ensure they can guide the development of their portfolio companies.
The firm is open to follow-on investments, especially if the company continues to align with their mission of addressing health inequities.
Specific details about the size of Syridex Bio's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.